Nu-Med Plus, Inc.
NUMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,607 | $3,937 | $7,269 | $1,282 |
| - Cash | $2 | $1 | $2 | $2 |
| + Debt | $100 | $100 | $100 | $100 |
| Enterprise Value | $2,705 | $4,036 | $7,366 | $1,380 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | 50% |
| EBITDA | -$10 | -$10 | $0 | $0 |
| % Margin | – | – | – | 0% |
| Net Income | -$12 | -$12 | -$20 | -$11 |
| % Margin | – | – | – | -1,759.2% |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 0% | 50% | -100% | – |
| Operating Cash Flow | -$13 | $0 | $0 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$13 | $0 | $0 | -$2 |